[Treatment of trichomonas vaginitis in the pregnant woman with Metronidazole (8 823 RP). Absence of teratogenic effects].
D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008431:Maternal-Fetal Exchange / Q000187:drug effects; D008795:Metronidazole / Q000627:therapeutic use*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*; D014247:Trichomonas Vaginitis / Q000188:drug therapy*
D008795:Metronidazole
Traitement par le métronidazole (8 832 RP) de la vaginite à trichomonas de la femme enceinte. Absence d'effets tératogènes.